NORdic trial of oral methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting multiple sclerosis (NORMIMS study): a randomised, placebo-controlled trial

P Sorensen; S Mellgren; A Svenningsson; I Elovaara; J Friksen; JL Frederiksen; A Beiske; K-M Myhr; L Sogaard; LV Søgaard; I Olsen; M Sandberg-Wollheim

doi:10.1016/s1474-4422(09)70085-7

NORdic trial of oral methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting multiple sclerosis (NORMIMS study): a randomised, placebo-controlled trial

P Sorensen
, S Mellgren
, A Svenningsson
, I Elovaara
, J Friksen
, JL Frederiksen
, A Beiske
, K-M Myhr
, L Sogaard
, LV Søgaard
, I Olsen
, M Sandberg-Wollheim

Research output: Contribution to journal › Article › Scientific › peer-review

94 Citations (Scopus)

Original language	English
Pages (from-to)	519-529
Journal	The Lancet Neurology
Volume	8
Issue number	6
DOIs	https://doi.org/10.1016/s1474-4422(09)70085-7
Publication status	Published - 2009
Publication type	A1 Journal article-refereed

Access to Document

10.1016/s1474-4422(09)70085-7

Cite this

Sorensen, P., Mellgren, S., Svenningsson, A., Elovaara, I., Friksen, J., Frederiksen, JL., Beiske, A., Myhr, K.-M., Sogaard, L., Søgaard, LV., Olsen, I., & Sandberg-Wollheim, M. (2009). NORdic trial of oral methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting multiple sclerosis (NORMIMS study): a randomised, placebo-controlled trial. The Lancet Neurology, 8(6), 519-529. https://doi.org/10.1016/s1474-4422(09)70085-7

@article{39935dd5e1cf4c7096702a62c561ae05,

title = "NORdic trial of oral methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting multiple sclerosis (NORMIMS study): a randomised, placebo-controlled trial",

author = "P Sorensen and S Mellgren and A Svenningsson and I Elovaara and J Friksen and JL Frederiksen and A Beiske and K-M Myhr and L Sogaard and LV S{\o}gaard and I Olsen and M Sandberg-Wollheim",

year = "2009",

doi = "10.1016/s1474-4422(09)70085-7",

language = "English",

volume = "8",

pages = "519--529",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier",

number = "6",

}

Sorensen, P, Mellgren, S, Svenningsson, A, Elovaara, I, Friksen, J, Frederiksen, JL, Beiske, A, Myhr, K-M, Sogaard, L, Søgaard, LV, Olsen, I & Sandberg-Wollheim, M 2009, 'NORdic trial of oral methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting multiple sclerosis (NORMIMS study): a randomised, placebo-controlled trial', The Lancet Neurology, vol. 8, no. 6, pp. 519-529. https://doi.org/10.1016/s1474-4422(09)70085-7

NORdic trial of oral methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting multiple sclerosis (NORMIMS study): a randomised, placebo-controlled trial. / Sorensen, P; Mellgren, S; Svenningsson, A et al.
In: The Lancet Neurology, Vol. 8, No. 6, 2009, p. 519-529.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - NORdic trial of oral methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting multiple sclerosis (NORMIMS study): a randomised, placebo-controlled trial

AU - Sorensen, P

AU - Mellgren, S

AU - Svenningsson, A

AU - Elovaara, I

AU - Friksen, J

AU - Frederiksen, JL

AU - Beiske, A

AU - Myhr, K-M

AU - Sogaard, L

AU - Søgaard, LV

AU - Olsen, I

AU - Sandberg-Wollheim, M

PY - 2009

Y1 - 2009

U2 - 10.1016/s1474-4422(09)70085-7

DO - 10.1016/s1474-4422(09)70085-7

M3 - Article

SN - 1474-4422

VL - 8

SP - 519

EP - 529

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 6

ER -